Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Dermtech Inc (DMTK)

Dermtech Inc (DMTK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 119,559
  • Shares Outstanding, K 30,040
  • Annual Sales, $ 11,840 K
  • Annual Income, $ -78,340 K
  • 60-Month Beta 1.49
  • Price/Sales 10.20
  • Price/Cash Flow N/A
  • Price/Book 0.67
Trade DMTK with:

Options Overview Details

View History
  • Implied Volatility 163.88% ( +35.70%)
  • Historical Volatility 74.45%
  • IV Percentile 99%
  • IV Rank 66.02%
  • IV High 214.70% on 06/23/22
  • IV Low 65.13% on 10/21/21
  • Put/Call Vol Ratio 0.14
  • Today's Volume 90
  • Volume Avg (30-Day) 287
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 9,833
  • Open Int (30-Day) 9,791

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.99
  • Number of Estimates 2
  • High Estimate -0.98
  • Low Estimate -0.99
  • Prior Year -0.68
  • Growth Rate Est. (year over year) -45.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.84 +3.65%
on 09/27/22
6.40 -37.81%
on 09/12/22
-1.44 (-26.57%)
since 08/29/22
3-Month
3.84 +3.65%
on 09/27/22
8.93 -55.43%
on 08/03/22
-1.63 (-29.06%)
since 06/29/22
52-Week
3.84 +3.65%
on 09/27/22
34.22 -88.37%
on 10/08/21
-28.10 (-87.59%)
since 09/29/21

Most Recent Stories

More News
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced the grant to 30 new employees of...

DMTK : 3.98 (-1.00%)
Will These Two Stocks Boom or Bust?

These two stocks have sky-high potential.

LMND : 20.99 (-6.59%)
DMTK : 3.98 (-1.00%)
DermTech, Inc. (DMTK) Reports Q2 Loss, Lags Revenue Estimates

DermTech, Inc. (DMTK) delivered earnings and revenue surprises of 2.94% and 14.49%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

DMTK : 3.98 (-1.00%)
BHG : 1.1200 (-5.08%)
DermTech Reports Second-Quarter 2022 Financial Results; Company Updates Full-Year 2022 Outlook

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today reported its second-quarter 2022 financial...

DMTK : 3.98 (-1.00%)
Earnings Preview: DermTech, Inc. (DMTK) Q2 Earnings Expected to Decline

DermTech, Inc. (DMTK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DMTK : 3.98 (-1.00%)
NTRA : 44.47 (-3.43%)
DermTech Appoints Chief Compliance Officer and SVP of Research and Development

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, has appointed two new members to its senior leadership...

DMTK : 3.98 (-1.00%)
DermTech Announces Release Date for Second-Quarter 2022 Financial Results

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, will host a conference call and webcast on Monday,...

DMTK : 3.98 (-1.00%)
DermTech Appoints Two New Board Members

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced the appointment of Kirk D. Malloy,...

DMTK : 3.98 (-1.00%)
NSTG : 12.72 (-7.49%)
DermTech Joins PeDRA Corporate Council, Supporting Efforts to Address Pediatric Skin Diseases

DermTech , Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today its membership in the Corporate...

DMTK : 3.98 (-1.00%)
Agiliti (AGTI) Stock Jumps 5.5%: Will It Continue to Soar?

Agiliti (AGTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road....

AGTI : 15.50 (-2.94%)
DMTK : 3.98 (-1.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

DermTech Inc. markets and develops products which facilitate early detection of skin cancers, assess inflammatory diseases and customize drug treatments. DermTech Inc., formerly known as Constellation Alpha Capital Corp., is based in La Jolla, United States.

See More

Key Turning Points

3rd Resistance Point 4.26
2nd Resistance Point 4.17
1st Resistance Point 4.08
Last Price 3.98
1st Support Level 3.89
2nd Support Level 3.81
3rd Support Level 3.71

See More

52-Week High 34.22
Fibonacci 61.8% 22.61
Fibonacci 50% 19.03
Fibonacci 38.2% 15.45
Last Price 3.98
52-Week Low 3.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar